Neuromodulation with Botulinum Toxin in Eyelid-Associated Ocular Surface Disease

Summary

Ocular surface disease (OSD) encompasses dry eye disease and eyelid-related disorders. Botulinum toxin, by reducing eyelid muscle tension, modulates eyelid tone and function, alleviating symptoms of eyelid-associated OSD (EAOSD), such as abnormal blink patterns and incomplete lid sealing. This paper explores botulinum toxin's role in treating EAOSD.

Abstract

Ocular surface disease (OSD) encompasses a range of conditions that not only include the well-described dry eye disease (DED) components - such as hyperosmolarity, inflammation, ocular surface damage, and neurosensory compromise - but also eyelid-related disorders. These can stem from anatomical abnormalities or as consequences of DED, leading to various mechanical and inflammatory issues. These may include friction between the eyelids and the globe; irregular blink mechanics; and incomplete protection or even frank exposure of the ocular surface. Eyelid-associated ocular surface disease (EAOSD) includes conditions such as superior limbic keratoconjunctivitis, orbicularis oculi spasm (Jumping Orbicularis Sign), lid wiper epitheliopathy, and tight eyelid syndrome. Botulinum toxin, produced by the bacterium Clostridium botulinum, works by blocking the release of acetylcholine at the neuromuscular junction, leading to temporary muscle weakening. When mindfully injected into the orbicularis oculi, frontalis, or tarsal plate, botulinum toxin may reduce muscle tension around the eyelids, which improves eyelid tone and anatomic apposition between the eyelid and ocular surface tissues. Botulinum toxin can also be used to address abnormal blink patterns, incomplete blinking, nocturnal lid seal insufficiency, and lagophthalmos. Such interventions may alleviate symptoms associated with EAOSD. This paper examines the applications of botulinum toxin in the treatment of EAOSD. Other applications of botulinum toxin for addressing photophobia and excess trigeminal nerve tone are separately addressable topics.

Introduction

While many practitioners and patients are familiar with dry eye disease (DED) and its associated pathophysiology - such as hyperosmolarity, inflammation, and neurosensory dysfunction - less attention has been given to how eyelid abnormalities contribute to ocular surface disease (OSD)¹. Eyelid-associated ocular surface disease (EAOSD) represents a complex interplay of anatomical, mechanical, and inflammatory factors that can cause or exacerbate OSD^2,3.

Disorders of the eyelids, whether stemming from anatomical anomalies or as sequelae of DED, can exacerbate t....

Protocol

The study received approval from the Colorado Multiple Institutional Review Board, conforms to the tenets of the Declaration of Helsinki, and informed consent was obtained from all participants.

1. Clean procedure set-up

1. Gather the necessary instruments and materials, including a sterile insulin syringe preloaded with botulinum toxin diluted to 4 units/0.1 mL in bacteriostatic saline. Prepare commercial-grade eyelid wipes for initial cleaning, alcohol pads for additional skin preparation, and 4 inch x 4 inch aesthetic gauze for post-injection compression. Ensure all materials are sterile and within expiration da....

Results

Figure 1 shows examples of the upper eyelid area treated with Botox injections. Among our three patients who underwent botulinum toxin injection for EAOSD (Table 1, Figure 2, Figure 3, and Figure 4), all demonstrated clinical improvement in ocular surface health without any changes to their existing OSD regimens. Post-injection findings included reduced superior corneal and conjunctival.......

Discussion

Botulinum neurotoxin, the most potent toxin known to humans and the causative agent of botulism, is produced by the anaerobic, spore-forming, gram-positive bacterium Clostridium botulinum²¹. It functions by blocking the release of acetylcholine at cholinergic presynaptic nerve terminals and neuromuscular synapses, leading to temporary paralysis of the affected tissues²¹. Type A is the most potent exotoxin and is the most commonly used botulinum toxin type in commer.......

Materials

List of materials used in this article

Name	Company	Catalog Number	Comments
4x4 esthetic gauze	Graham Spa Essentials	52509	Nonwoven esthetic wipes, 4"x4", 200 wipes per package
Alcohol prep pads	Curad	CUR090737RB	Medium, 2-ply, 100-count
Commercial grade cleansing wipe	MYZE	—	Daily Lid Wipe for eyelid hygiene
Cosmetic Botulinum Toxin	AbbVie	NDC 0023-923201	Botox for injection, 100 units/vial
Insulin syringe	Brandzig	CMP2602	1 mL 31G x 8mm insulin syringe with fixed needle